Pharmaceutical companies are dedicated in giving the utmost possible highest product and service quality to its people. World pharma and labs are integrated in order to deliver the demands. One of the main players in the pharmaceutical industry is the Pfizer Inc.

Pfizer Inc. (also regarded as the Pfizer Drug Company) is a US-based pharmaceutical corporation with the corporate headquarters in New York City (US Headquarters), with its R&D HQ in Groton, Connecticut together with several office locations around the world. It is regarded as one of the world’s largest pharmaceutical companies ever to exist in a long span of time. It is listed on the NYSE its shares have been a component of the DJIA since the year of 2004.

Pfizer Inc. Headquarters Address

Contact

Address: Pfizer HQ NYC: 235 East, 42nd Street, New York, New York 10017, USA
Contact number: 212-733-2323
Website: www.pfizer.com

Key People/Executives for Pfizer Inc.

Pfizer Inc. Profile/Overview

Charles Pfizer and Charles F.Erhart are the initial founders of Pfizer Chemicals in New York in the year 1849 nearly two centuries ago, as the manufacturers of fine chemicals and more. The alliance grew, with their major turning points being the creation of the anti-parasitic drug named Santonin and Citric Acid.

As the twentieth century passes, Pfizer was doing significantly well. It was only during the WWII when Pfizer produced massive supplies of Penicillin for the victims of the war and transported it to Europe. It gave a good impression, gaining lot of popularity worldwide. By the mid-20^th century, it expanded through the world into nearly ten other countries including the UK, Iran, Belgium, Brazil and Canada.

The company was responsible of breakthrough drugs that it discovered and marketed. Naming some are Zoloft (the anti-depressant drug), Lipitor (the cholesterol lowering drug), Viagra (to treat sexual dysfunction), Aricept (anti-Alzheimer’s drug) and Zithromax (an antibiotic).

Pfizer also made several aquisitions. Warner-Lambart, Wyeth and Pharmacia are some of the major pharmaceutical companies that they acquired. Off late, Pfizer discontinued most of its research units and has been focusing on developing its spin-off named Zoetis that will be involved in agricultural and animal health field.

Issues in the world health caught Pfizer’s concern, either giving away drugs at little to no cost in the developing countries. The company donates Fluconazole to the countries where AIDS is highly prevalent at no cost. The company, together with Gates Foundation, also gives away contraceptive drugs at significantly low rates to the women of the developing countries.

For more than a century with more than 60 types of drugs that Pfizer presently in use today, the brand plays a major role in the pharmaceutical world and will persist for the future to come.

Pfizer Inc. Products/Capabilities

Pfizer Inc. is dedicated to discovering, developing, manufacturing, and selling healthcare products internationally. It operates through two main segments. These are:

1. Pfizer Innovative Health (IH)
2. Pfizer Essential Health (EH)

The IH segment develops and commercializes Pfizer products of medicines and vaccines, and consumer healthcare products in various therapeutic areas such as:

1. Internal medicine
2. Vaccines
3. Oncology
4. Inflammation and immunology
5. Rare diseases
6. Consumer healthcare, such as dietary supplements, pain management, gastrointestinal
7. Respiratory and personal care

These segment brands of the IH are as follows:

1. Prevnar 13
2. Xeljanz
3. Eliquis
4. Lyrica
5. Enbrel
6. Viagra
7. Ibrance
8. Xtandi
9. Advil
10. Centrum

The EH segment offers the following products dedicated in delivering essential health:

1. Branded generic products
2. Sterile injectable products
3. Biosimilars
4. Infusion systems

Brands of the EH segment are as follows:

1. Lipitor
2. Premarin family
3. Norvasc
4. Lyrica
5. Celebrex
6. Pristiq

Corporate and business services/agreements of Pfizer are as follows:

1. Contract manufacturing business. The company has licensing agreements with Cellectis SA and AstraZeneca plc
2. Collaborative agreements with Eli Lilly & Company and Merck KGaA
3. Research collaboration and license agreement with HitGen Ltd. to build and screen DNA-encoded libraries in order to discover small molecule leads to be used in drug development
4. Agreement with InSphero AG to develop a predictive toxicology assay using InSphero 3D InSight human liver microtissues for predicting drug induced liver injury

Pharmaceutical and healthcare companies are highly dedicated in giving the utmost service and product pipelines to its ventures. These companies are merged together in order to deliver the demands. Mentioning one of the key players in the pharmaceutical and medical industry is the C.R. Bard, Inc.

C. R. Bard, Inc., (Bard C.R. Inc) recently shortened to Bard, headquartered in their main office in Murray Hill, New Jersey, USA and medical locations around the world, is one of the leaders in developing, manufacturing, and marketing of medical technologies in the following medical fields or specialties: vascular, urology, oncology, and surgical specialties. It creates their dedicated access system, peripheral vascular products, medical supplies and devices in pharmaceuticals. In April 2017, an announcement was done by Bard that it will be acquired by Becton Dickinson.

R. Bard, Inc. Headquarters Address

Contacts

• Mailing address: 730 Central Avenue, Murray Hill, NJ 07974, USA
• Contact number: 908-277-8000
• Website: www.crbard.com
• Employee email: TS.ServiceDesk@crbard.com
• Subsidiaries
  1. Bard Medical Div.
  2. Davol Inc.
  3. Bard Int’l
  4. Venetec Int’l, Inc.

Key People/Executives for C. R. Bard, Inc.

C. R. Bard, Inc. Profile/Overview

C. R. Bard, Inc. was founded in NYC by a man named Charles R. Bard in 1907. The first venture involved importing the medicine Gomenol, which was used to treat urinary discomfort. Formal incorporation was done in 1923, and three years later, in 1926, Charles let the company be sold to John F. Willits and Edson L. Outwin for $18,000. Under Willits and Outwins, expansion was done into the catheter business, introducing the Foley catheter in 1934 and the America Woven Catheter in 1940.

In 1948, Bard’s yearly sales totalled $1 million for the first time ever, and the company moved its headquarters from New York City to Summit, New Jersey. In 1954, Dr. DeBakey, a scientist from the company, developed the first arterial prosthesis. Three years later the selling Foley catheters that came in sterile packaging was done by Bard for the first time. Furthermore it continued its actions to innovate in the world of catheters, rolling out the Bipolar Temporary Pacing catheter in 1958 and the first latex balloon catheter in 1960. In 1961, expansions were done and began manufacturing products related to cardiology, radiology, and anesthesiology.

IPO was done by Bard in 1963 and was listed on the New York Stock Exchange in the year of 1968. Introduction of variety of new health care products was commenced by the company since that time. Its net sales reached to an amount of over $1 billion. Around the year of 2012, Bard made an acquisition to the company Lutonix.
On April 23, 2017, announcement was done that Becton Dickinson would acquire them for $24 billion.

C. R. Bard, Inc. Products/Capabilities

• C. R. Bard, Inc., together with its merged companies and subsidiaries, is dedicated in designing, manufacturing, packaging, distributing, and selling medical, surgical, diagnostic, and patient care devices internationally. The company offers the following:
  1. Vascular products, such as, chronic total occlusion catheters, guidewires, percutaneous transluminal angioplasty, cathetersfabrics, meshes, introducers, and accessories
  2. Valvuloplasty balloons; peripheral vascular stents, self-expanding and balloon-expandable covered stents, and vascular grafts; vena cava filters
  3. Biopsy devices; and a range of minimally invasive devices for the treatment of peripheral vascular and end-stage renal diseases
  4. Urology products, including foley catheters to reduce the rate of urinary tract infections
  5. Fecal incontinence products
  6. Brachytherapy devices and radioactive seeds for the treatment of prostate cancer
  7. Intermittent urinary drainage catheters, and urine monitoring and collection systems
  8. Ureteral stents
  9. Specialty devices for stone removal procedures
  10. Surgical slings and pelvic floor repair products
  11. Catheter stabilization devices; and products for therapeutic hypothermia.
  12. Oncology products, such as specialty vascular access catheters and ports, vascular access ultrasound devices, dialysis access catheters, and enteral feeding devices to treat and manage various cancers, and other diseases and disorders
  13. Surgical specialty products comprising implanted grafts and fixation devices for hernia and soft tissue repairs
  14. Hemostats and surgical sealants, as well as irrigation, wound drainage, and original equipment manufacturers products.

Devices in the medical world are made in quality to its customers and potential ventures. Such companies dedicated to make these are integrated in order to deliver the demands.

Mentioning one of the key players in this industry is the Boston Scientific Corporation.

Boston Scientific Corporation (known as Boston Scientific) is a corporate international leader in the development, manufacturing and marketing of medical devices which showcases products in the range of interventional medical specialties, including the following medical disciplines: interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology. They are also known in developing diabetes products.

Boston Scientific Corporation Headquarters Address

Contact

• Mailing address: 300 Boston Scientific Way, Marlborough, MA 01752, USA
• Boston Scientific Japan: Nikko Building,1-14-11 Nishi Shinjuku, Shinjuku-ku, Tokyo,  160-0023, Japan
• Phone number: 508-683-4000
• Website: www.bostonscientific.com

Subsidiaries

• Guidant
• Cameron Health
• Symetis SA
• Target Therapeutics Inc.
• Cardiac Pacemakers, Inc.

Key People/Executives for Boston Scientific Corporation

Boston Scientific Corporation Profile/Overview

• Forming of the BSC was done on June 29, 1979 as a holding company for a medical products company called Medi-Tech, and to position the company for growth in interventional medicine. IPO was made by the company on May 19, 1992.
  Approval to The Taxus Stent was made in 2003 in Europe and other countries and approved in the United States by the FDA in March 2004. It was considered as the second drug-eluting stent approved in the USA.
• On April 21, 2006, the company made an acquisition to their longtime competitor Guidant for $27.2 billion. It was then split between BSC and Abbott Laboratories.
• Forming of Navilyst Medical was done in February 2008 from Boston Scientific’s Fluid Management and Vascular Access business units.

Boston Scientific Corporation Products/Capabilities

Boston Scientific Corporation is highly dedicated in developing, manufacturing, and marketing medical devices for use in various interventional medical specialties internationally. It operates through three segments:

1. Cardiovascular
2. Rhythm Management
3. MedSurg

The company offers the following products:

1. Interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease
2. Other coronary therapy products to treat atherosclerosis
3. Intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as certain peripheral vessels
4. Structural heart therapy systems
5. Stents, balloon catheters, wires, peripheral embolization devices, and vena cava filters used to treat peripheral arterial disease
6. Biliary stents, drainage catheters, and micro-puncture sets to treat, diagnose, and ease benign and malignant tumors.
7. Cardiac rhythm management devices, such as implantable cardioverter defibrillator systems to detect and treat abnormally fast heart rhythms
8. Implantable cardiac resynchronization therapy pacemaker systems used to treat heart failure
9. Medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising steerable radio frequency ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories
10. Products to diagnose and treat diseases of the pulmonary and gastrointestinal conditions
11. Devices to diagnose, treat, and ease pulmonary disease systems within the airway and lungs
12. Products to treat urinary stone disease and benign prostatic hyperplasia
13. Mid-urethral sling products, sling and graft materials, pelvic floor reconstruction kits, and suturing devices
14. And spinal cord stimulator systems for the management of chronic pain